Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Up – Here’s Why

Shares of Eurofins Scient (OTCMKTS:ERFSF) gapped up prior to trading on Monday . The stock had previously closed at $78.9920, but opened at $82.96. Eurofins Scient shares last traded at $81.9440, with a volume of 42 shares trading hands.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on ERFSF shares. BNP Paribas Exane upgraded shares of Eurofins Scient to an “outperform” rating in a report on Monday, January 5th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Eurofins Scient in a research report on Wednesday, October 29th. Finally, Citigroup restated a “neutral” rating on shares of Eurofins Scient in a research report on Monday, February 2nd. One investment analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold”.

Eurofins Scient Stock Performance

The business’s 50 day moving average price is $77.31 and its two-hundred day moving average price is $74.84. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.19 and a current ratio of 1.26.

Eurofins Scient Company Profile

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.